Search

Your search keyword '"Dipankar Ghosh"' showing total 13 results
Start Over Author "Dipankar Ghosh" Journal indian heart journal
13 results on '"Dipankar Ghosh"'

1. Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI–HF in COVID 19 times study – 'The COVID C–HF study')

Author

Jayagopal P. B, Ramakrishnan S, Mohanan P. P, Jabir A, Venugopal K, M.K. Das, Santhosh K, Syam N, J. Ezhilan, Rajeev Agarwal, Vaidyanathan P R, Ahmed Hussain Choudhary, Meena C B, Amit Malviya, Arun Gopi, Chopra V K, Stigi Joseph, Krishna Kishore Goyal, John F. John, Sandeep Bansal, Harikrishnan S, Praveen Nagula, Johny Joseph, Ajit Bagawat, Sandeep Seth, Urmil Shah, Pravin K. Goel, P.K. Asokan, K.K. Sethi, Satyavan Sharma, (Lt.Gen)Anup Banerji, Sunandan Sikdar, ManojKumar Agarwala, Sharad Chandra, BishwaBhushan Bharti, S.M. Ashraf, Smit Srivastava, B. Kesavamoorthy, Harinder Kumar Bali, Dipak Sarma, Rajendra Kumar Jain, Sameer I. Dani, B.H. Natesh, Rabindra Nath Chakraborty, Vivek Gupta, Narendra Nath Khanna, Dipankar Mukhopadhyay, Subroto Mandal, Biswajit Majumder, Sridhar L, Meennahalli Palleda Girish, DipakRanjan Das, Tom Devasia, Bhavesh Vajifdar, Tanuj Bhatia, Zia Abdullah, Sanjeev Sharma, Sudeep Kumar, Mathew Lincy, Nitish Naik, Dhiman Kahali, Dhurjati Prasad Sinha, Dipankar Ghosh Dastidar, Gurpreet Sing Wander, Rakesh Yadav, Satyendra Tewari, Suman Bhandari, Pratap Chandra Rath, Vijay Harikisan Bang, Debabrata Roy, ParthoSarathi Banerjee, S. Shanmugasundaram, and Geevar Zachariah

Subjects
COVID-19, Acute heart failure, Acute decompensated heart failure, GDMT in heart failure, Surgery, RD1-811, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Objectives: The presentation and outcomes of acute decompensated heart failure (ADHF) during COVID times (June 2020 to Dec 2020) were compared with the historical control during the same period in 2019. Methods: Data of 4806 consecutive patients of acute HF admitted in 22 centres in the country were collected during this period. The admission patterns, aetiology, outcomes, prescription of guideline-directed medical therapy (GDMT) and interventions were analysed in this retrospective study. Results: Admissions for acute heart failure during the pandemic period in 2020 decreased by 20% compared to the corresponding six-month period in 2019, with numbers dropping from 2675 to 2131. However, no difference in the epidemiology was seen. The mean age of presentation in 2019 was 61.75 (±13.7) years, and 59.97 (±14.6) years in 2020. There was a significant decrease in the mean age of presentation (p = 0.001). Also. the proportion of male patients decreased significantly from 68.67% to 65.84% (p = 0.037). The in-hospital mortality for acute heart failure did not differ significantly between 2019 and 2020 (4.19% and 4.,97%) respectively (p = 0.19). The proportion of patients with HFrEF did not change in 2020 compared to 2019 (76.82% vs 75.74%, respectively). The average duration of hospital stay was 6.5 days. Conclusion: The outcomes of ADHF patients admitted during the Covid pandemic did not differ significantly. The length of hospital stay remained the same. The study highlighted the sub-optimal use of GDMT, though slightly improving over the last few years.

Published
2023
Full Text
View/download PDF

2. COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA)

Author

Abdullakutty Jabir, Geevar Zachariah, Padinhare Purayil Mohanan, Mohit Dayal Gupta, Sivasubramanian Ramakrishnan, Chandra Bhan Meena, L. Sridhar, Meennahalli Palleda Girish, Dipak Ranjan Das, Anshul Gupta, Praveen Nagula, Tom Devasia, Bhavesh Vajifdar, Kamlesh Thakkar, Urmil Shah, Tanuj Bhatia, Smit Srivastava, Sanjeev Sharma, Priya Kubendiran, Pathiyil Balagopalan Jayagopal, Sudeep Kumar, Deepthy Sadanandan, Lincy Mathew, Nitish Naik, Anup Banerji, S.M. Ashraf, P.K. Asokan, Bishwa Bhushan Bharti, Biswajit Majumder, Dhiman Kahali, Dhurjati Prasad Sinha, Dipak Sharma, Dipankar Ghosh Dastidar, Dipankar Mukhapdhyay, Gurpreet Sing Wander, Harinder Kumar Bali, B. Kesavamoorthy, Manoj Kumar Agarwala, Narendra Nath Khanna, B.H. Natesh, Pravin K. Goel, Rabindra Nath Chakraborty, Rajendra Kumar Jain, Rakesh Yadav, L. Sameer Dani, Satyavan Sharma, Satyendra Tewari, K.K. Sethi, Sharad Chandra, Subrato Mandal, Suman Bhandari, Sundandan Sikdar, Vivek Gupta, Pratap Chandra Rath, Vijay Harikisan Bang, Debabrata Roy, Mrinal Kanti Das, and Partho Sarathi Banerjee

Subjects
COVID positive STEMI, MI during COVID, STEMI and COVID, STEMI during COVID, STEMI management, Surgery, RD1-811, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Objective: To find out differences in the presentation, management and outcomes of COVID-19 infected STEMI patients compared to age and sex-matched non-infected STEMI patients treated during the same period. Methods: This was a retrospective multicentre observational registry in which we collected data of COVID-19 positive STEMI patients from selected tertiary care hospitals across India. For every COVID-19 positive STEMI patient, two age and sex-matched COVID-19 negative STEMI patients were enrolled as control. The primary endpoint was a composite of in-hospital mortality, re-infarction, heart failure, and stroke. Results: 410 COVID-19 positive STEMI cases were compared with 799 COVID-19 negative STEMI cases. The composite of death/reinfarction/stroke/heart failure was significantly higher among the COVID-19 positive STEMI patients compared with COVID-19 negative STEMI cases (27.1% vs 20.7% p value = 0.01); though mortality rate did not differ significantly (8.0% vs 5.8% p value = 0.13). Significantly lower proportion of COVID-19 positive STEMI patients received reperfusion treatment and primary PCI (60.7% vs 71.1% p value=< 0.001 and 15.4% vs 23.4% p value = 0.001 respectively). Rate of systematic early PCI (pharmaco-invasive treatment) was significantly lower in the COVID-19 positive group compared with COVID-19 negative group. There was no difference in the prevalence of high thrombus burden (14.5% and 12.0% p value = 0.55 among COVID-19 positive and negative patients respectively) Conclusions: In this large registry of STEMI patients, we did not find significant excess in in-hospital mortality among COVID-19 co-infected patients compared with non-infected patients despite lower rate of primary PCI and reperfusion treatment, though composite of in-hospital mortality, re-infarction, stroke and heart failure was higher.

Published
2023
Full Text
View/download PDF

3. Strain echocardiography in predicting LV dysfunction in RV apical pacing

Author

Goutam Datta, Dipankar Ghosh Dastidar, and Hrishikesh Chakraborty

Subjects
Strain Echocardiography, RV apical pacing, LV dysfunction, Heart failure, GLS, Surgery, RD1-811, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Right ventricular (RV) pacing is associated with a reduction in left ventricular (LV) systolic function, thought to be mediated by pacing-induced ventricular dyssynchrony. The prevalence of heart failure after RV pacing is reported to range from 31±3%. We studied 60 subjects with high-grade atrioventricular block and Complete Heart Block (CHB) scheduled to undergo right ventricular apical pacing. 2D echocardiography was done at baseline, 1 month and 12 months. Pacing-induced cardiomyopathy was defined as a reduction in LVEF to

Published
2023
Full Text
View/download PDF

5. Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI–HF in COVID 19 times study – “The COVID C–HF study”)

Author

B, Jayagopal P., S, Ramakrishnan, P, Mohanan P., A, Jabir, K, Venugopal, Das, M.K., K, Santhosh, N, Syam, Ezhilan, J., Agarwal, Rajeev, P R, Vaidyanathan, Choudhary, Ahmed Hussain, C B, Meena, Malviya, Amit, Gopi, Arun, V K, Chopra, Joseph, Stigi, Goyal, Krishna Kishore, John, John F., Bansal, Sandeep, S, Harikrishnan, Nagula, Praveen, Joseph, Johny, Bagawat, Ajit, Seth, Sandeep, Shah, Urmil, Goel, Pravin K., Asokan, P.K., Sethi, K.K., Sharma, Satyavan, Banerji, (Lt.Gen)Anup, Sikdar, Sunandan, Agarwala, ManojKumar, Chandra, Sharad, Bharti, BishwaBhushan, Ashraf, S.M., Srivastava, Smit, Kesavamoorthy, B., Bali, Harinder Kumar, Sarma, Dipak, Jain, Rajendra Kumar, Dani, Sameer I., Natesh, B.H., Chakraborty, Rabindra Nath, Gupta, Vivek, Khanna, Narendra Nath, Mukhopadhyay, Dipankar, Mandal, Subroto, Majumder, Biswajit, L, Sridhar, Girish, Meennahalli Palleda, Das, DipakRanjan, Devasia, Tom, Vajifdar, Bhavesh, Bhatia, Tanuj, Abdullah, Zia, Sharma, Sanjeev, Kumar, Sudeep, Lincy, Mathew, Naik, Nitish, Kahali, Dhiman, Sinha, Dhurjati Prasad, Dastidar, Dipankar Ghosh, Wander, Gurpreet Sing, Yadav, Rakesh, Tewari, Satyendra, Bhandari, Suman, Chandra Rath, Pratap, Bang, Vijay Harikisan, Roy, Debabrata, Banerjee, ParthoSarathi, Shanmugasundaram, S., and Zachariah, Geevar

Published
2023
Full Text
View/download PDF

6. COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA)

Author

Jabir, Abdullakutty, Geevar Zachariah, Mohanan, Padinhare Purayil, Gupta, Mohit Dayal, Ramakrishnan, Sivasubramanian, Meena, Chandra Bhan, Sridhar, L., Girish, Meennahalli Palleda, Das, Dipak Ranjan, Gupta, Anshul, Praveen Nagula, Tom Devasia, Bhavesh Vajifdar, Kamlesh Thakkar, Urmil Shah, Tanuj Bhatia, Smit Srivastava, Sanjeev Sharma, Priya Kubendiran, Jayagopal, Pathiyil Balagopalan, Sudeep Kumar, Deepthy Sadanandan, Lincy Mathew, Nitish Naik, Anup Banerji, Ashraf, S.M., Asokan, P.K., Bharti, Bishwa Bhushan, Majumder, Biswajit, Dhiman Kahali, Sinha, Dhurjati Prasad, Sharma, Dipak, Dastidar, Dipankar Ghosh, Dipankar Mukhapdhyay, Wander, Gurpreet Sing, Bali, Harinder Kumar, Kesavamoorthy, B., Agarwala, Manoj Kumar, Khanna, Narendra Nath, Natesh, B.H., Goel, Pravin K., Chakraborty, Rabindra Nath, Jain, Rajendra Kumar, Rakesh Yadav, Sameer Dani, L., Satyavan Sharma, Satyendra Tewari, Sethi, K.K., Sharad Chandra, Mandal, Subrato, Bhandari, Suman, Sikdar, Sundandan, Vivek Gupta, Rath, Pratap Chandra, Bang, Vijay Harikisan, Debabrata Roy, Das, Mrinal Kanti, and Banerjee, Partho Sarathi

Published
2023
Full Text
View/download PDF

10. Intravascular ultrasound assessment of non-culprit coronary arteries in patients suffering from ST elevation myocardial infarction

Author

Prayank Jain, Santanu Guha, Siddhartha Mani, Dipankar Ghosh Dastidar, and Arnab Roy

Subjects
medicine.medical_specialty, RD1-811, medicine.diagnostic_test, business.industry, Culprit, Coronary arteries, medicine.anatomical_structure, St elevation myocardial infarction, RC666-701, Internal medicine, Intravascular ultrasound, behavior and behavior mechanisms, Cardiology, Diseases of the circulatory (Cardiovascular) system, Medicine, Surgery, In patient, Cardiology and Cardiovascular Medicine, business
Published
2015
Full Text
View/download PDF

11. Role of tenecteplase in peripheral embolic disease

Author

Amal Kumar, Bannerjee and Dipankar Ghosh, Dastidar

Subjects
Peripheral Vascular Diseases, Fibrinolytic Agents, Thromboembolism, Tissue Plasminogen Activator, Tenecteplase, Humans, Thrombolytic Therapy
Published
2011

12. Biochemical markers in acute myocardial infarction.

Author

Banerjee AK and Dastidar DG

Subjects
Humans, Predictive Value of Tests, Prognosis, Biomarkers blood, Early Diagnosis, Myocardial Infarction blood, Myocardial Infarction diagnosis
Published
2011

13. Role of tenecteplase in peripheral embolic disease.

Author

Bannerjee AK and Dastidar DG

Subjects
Humans, Tenecteplase, Fibrinolytic Agents therapeutic use, Peripheral Vascular Diseases drug therapy, Thromboembolism drug therapy, Thrombolytic Therapy methods, Tissue Plasminogen Activator therapeutic use
Published
2010

Catalog

Books, media, physical & digital resources
See catalog results